Exciting News, Employsure is now Peninsula. We're building a new website to make your experience even better. While we're working on it, your online experience might be across both Employsure and Peninsula sites

Client?
Call Now
  1. Home
  2. Media releases
  3. Can employers implement rapid antigen testing in the workplace

Can employers implement rapid antigen testing in the workplace?

Published November 8, 2021 (last updated on June 28, 2024) | Adam Wyatt - Content Writer

Image

Detecting COVID-19 through the use of rapid antigen testing may be an option for some businesses but may be a requirement for others to meet their health and safety obligations.

Vaccination related calls to Peninsula’s dedicated employer Advice Line surged a further 187% in October – up almost 8000% since the start of the year.

But with rapid antigen testing now available for at-home use as of 1 November, or through workplaces under the supervision of a health practitioner, employers have been given another option to help maximise safety.

Implementing rapid antigen testing:

Businesses only need to implement rapid antigen testing if a government direction or industry standard requires them to do so. Otherwise, the tests may be an alternative control measure to manage COVID-19 transmission risks for business owners, subject to the results of any risk assessment they carry out.

“Employers who want to implement rapid antigen testing in their business must know that without a legal requirement, they can only require an employee to take a rapid antigen test if the direction is considered lawful and reasonable. The testing must be connected to the employee’s employment, the nature of their workplace, and is considered necessary for an employer to know the employee’s fitness to work,” said Peninsula health and safety manager Larry Drewsen.

“Employers should first undertake a risk assessment in consultation with workers and identify rapid antigen testing as a reasonable measure to control the risk of COVID-19 transmission. This can include implementing a rapid antigen policy. Employers can then direct staff to take a test in line with their policy and risk management plan.

“While rapid antigen testing may be an effective control measure to address infection transmission risks, alternative measures, such as providing PPE, practicing hand hygiene, workplace cleaning and a detailed infection control policy may still be required to adequately address health risks and meet health and safety obligations.”

Employee refusal:

If a government or public health direction requires an employer to implement rapid antigen testing in their workplace, the employer can direct their employee to comply with the law.

As an employee’s refusal to take a test will flow from either a refusal to comply with the law or the employer’s policy, the employer may be able to commence a disciplinary process with the employee.

Positive result:

Employers who introduce rapid antigen testing must pay for the employee’s test kit. If an employee purchases a test kit at the direction of the employer, the employer must reimburse them the cost. If that employee returns a positive test result, they must be paid for time worked up until the results are received.

“If an employee returns a positive result, employers must direct them to stay out of the workplace, immediately take a standard COVID-19 test and communicate their result as soon as they receive it, as well as follow any government advice or regulations with respect to testing and self-isolating,” continued Mr Drewsen.

“If the subsequent standard test is positive, then permanent employees are eligible to take personal leave for the full period of absence. If negative, the employee is not entitled to payment in the ordinary course (but will be permitted to work). Annual leave can also be taken by mutual agreement.”

 

Media enquiries:

[email protected]

Latest Media Releases

Have a question?

Peninsula Logo

Not a client yet?

1300 207 182

Existing clients call (AU)

1300 651 415

Existing clients call (overseas)

+61 2 8123 3640

Peninsula HQ

Level 6/180 Thomas St, Sydney NSW 2000

Copyright © 2024 Employsure Pty Ltd. ABN 40 145 676 026

Peninsula Protect is a financial product issued by Peninsula Mutual Limited ACN 630 256 478, AFS Licence No. 544232. Peninsula Mutual Limited has appointed Peninsula Australia Pty Ltd as its Authorised Representative 001274577 to distribute the product and provide general advice. To decide if this product is right for you, please read the Peninsula Protect Product Disclosure Statement (PDS) and Target Market Determination.